Part of Athagoras
                                                                                                                                                                                               

Can AI write Technical Documentation? And if it can… what happens to Regulatory Affairs?
This might be one of the most burning questions of 2026.

AI can already:

🟦Structure Clinical Evaluation Reports
🟦Summarize scientific literature
🟦Draft Risk Management sections
🟦Reformat Annex II documentation under MDR
🟦Support 510(k) narratives
🟦Compare regulatory documents versions and assess change impact

Within 2–3 years, it will likely do this faster, cheaper, and more consistently.

Will AI replace your Regulatory Affairs team?
Not so fast.

Under Medical Device Regulation and according to the U.S. Food and Drug Administration, the legal manufacturer remains fully responsible for the accuracy, completeness, and compliance of submissions, regardless of the tools used.

AI can draft.

But it cannot take legal accountability, interpret regulatory nuance across jurisdictions, defend documentation during an inspection, or exercise regulatory judgment.

The disruption will not eliminate Regulatory Affairs, but it will compress it.
Fewer document compilers.

More senior strategists.
More AI governance.
More cross-functional regulatory-commercial translators.

By 2027, RA may look very different.
Not smaller.
More strategic.
And accountability will matter more than ever.

How do you think AI is shaping the future of Regulatory Affairs?

While you focus on innovation, we take care of the regulatory path!